Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO)
CUSIP: 09075F305
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 138,961,039
- Total 13F shares
- 1
- Share change
- 0
- Total reported value
- $1
- Price per share
- $1.00
- Number of holders
- 1
Quarterly Holders Quick Answers
What is CUSIP 09075F305?
CUSIP 09075F305 identifies BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 09075F305:
Top shareholders of BNGO - Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Soheil Shams |
3/4/5
|
Chief Informatics Officer |
—
mixed-class rows
|
5,556,479
mixed-class rows
|
$3,217,163 | — | 15 Feb 2022 | |
| Lincoln Alternative Strategies LLC |
13D/G
|
— |
5.4%
|
525,000
|
$2,021,250 | $0 | 17 Sep 2025 | |
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
5%
|
508,415
|
$1,957,398 | $0 | 16 Sep 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
9.9%
|
1,129,411
|
$1,795,763 | +$171,307 | 31 Dec 2025 | |
| Lind Global Fund III LP |
13D/G
|
— |
9.4%
|
1,050,000
|
$1,669,500 | +$851,703 | 31 Dec 2025 | |
| Iroquois Capital Management, LLC |
13D/G
|
Richard Abbe |
5%
|
98,944
|
$1,088,384 | $0 | 30 Sep 2025 | |
| Ayrton Capital LLC |
13D/G
|
— |
10%
|
528,245
|
$903,140 | $0 | 30 Sep 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
3%
|
337,777
|
$517,000 | — | 31 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
1.5%
|
168,453
|
$257,733 | — | 31 Dec 2025 | |
| Christopher P. Stewart |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
281,373
|
$180,810 | — | 12 May 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.73%
|
82,307
|
$125,930 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
66,766
|
$102,153 | — | 31 Dec 2025 | |
| CARRET ASSET MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
44,100
|
$67,473 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.36%
|
40,513
|
$61,985 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
37,000
|
$56,610 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.2%
|
22,170
|
$33,920 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
20,519
|
$31,394 | — | 31 Dec 2025 | |
| FLAGSHIP HARBOR ADVISORS, LLC |
13F
|
Company |
0.06%
|
4,000
|
$28,440 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
5,725
mixed-class rows
|
$28,295 | — | 31 Dec 2025 | |
| R Squared Ltd |
13F
|
Company |
0.12%
|
13,771
|
$21,070 | — | 31 Dec 2025 | |
| Gulsen Kama |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
91,000
mixed-class rows
|
$20,320 | — | 03 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
9,697
mixed-class rows
|
$18,396 | — | 31 Dec 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.09%
|
10,210
|
$15,621 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.09%
|
9,937
|
$15,204 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
8,453
|
$12,933 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
5,731
|
$8,763 | — | 31 Dec 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
—
mixed-class rows
|
1,213
mixed-class rows
|
$8,578 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
mixed-class rows
|
3,555
mixed-class rows
|
$5,489 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
—
mixed-class rows
|
1,382
mixed-class rows
|
$2,505 | — | 31 Dec 2025 | |
| R. Erik Holmlin |
3/4/5
|
PRESIDENT AND CEO, Director |
—
mixed-class rows
|
71,141
mixed-class rows
|
$1,822 | — | 17 Feb 2026 | |
| Concord Wealth Partners |
13F
|
Company |
0.01%
|
1,000
|
$1,530 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
100
|
$1,000 | — | 31 Dec 2025 | |
| Mark Oldakowski |
3/4/5
|
CHIEF OPERATING OFFICER |
—
mixed-class rows
|
28,632
mixed-class rows
|
$984 | — | 17 Feb 2026 | |
| Allworth Financial LP |
13F
|
Company |
—
mixed-class rows
|
106
mixed-class rows
|
$721 | — | 31 Dec 2025 | |
| Alka Chaubey |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
28,381
mixed-class rows
|
$708 | — | 17 Feb 2026 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
224
|
$343 | — | 31 Dec 2025 | |
| Jonathan Dixon V |
3/4/5
|
GENERAL COUNSEL |
—
mixed-class rows
|
26,380
mixed-class rows
|
$289 | — | 17 Feb 2026 | |
| Mark Adamchak |
3/4/5
|
Principal Accounting Officer |
—
mixed-class rows
|
11,150
mixed-class rows
|
$286 | — | 17 Feb 2026 | |
| SSA SWISS ADVISORS AG |
13F
|
Company |
0%
|
37
|
$264 | — | 31 Dec 2025 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
—
mixed-class rows
|
23
mixed-class rows
|
$141 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
mixed-class rows
|
31
mixed-class rows
|
$53 | — | 31 Dec 2025 | |
| HHM Wealth Advisors, LLC |
13F
|
Company |
0%
|
6
|
$43 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
13
|
$20 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
11
|
$17 | — | 31 Dec 2025 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
3
|
$5 | — | 31 Dec 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
2
|
$3 | — | 31 Dec 2025 | |
| Ancora Advisors LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2025 | |
| Medallion Wealth Advisors, LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2025 | |
| Aviso Financial Inc. |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 | |
| Richard Shippy |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
550,000
|
— | — | 15 Feb 2022 |
Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q1 2026
As of 31 Mar 2026,
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1 shares.
The largest 1 holders included
Ancora Advisors LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q1 2026 holders
1
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.